Our long term goal is to understand the mechanisms that control the formation and maintenance of the CNS and PNS myelin. PO, the major protein of PNS myelin, participated in the formation and compaction of the myelin lamellae. PO is esterified with long chain fatty acids, as is PLP, the major protein of CNS myelin. We hypothesize that acylation plays a role in the process of myelin synthesis and maintenance. The present studies are aimed at determining the fundamental aspects of the biology of PO acylation.
Our specific aims are: 1. To study the metabolism of the fatty bound to PO using a nerve slice system. Double-label pulse and pulse chase experiments, combined with subcellular fractionation will be used to identify the membranes in which acylation of PO takes place. We will establish the relationship between acylation and the other PO posttranslational modifications by using inhibitors of protein N-glycosylation and phosphorylation. We will also correlate the extent of PO synthesis and acylation during nerve development to gain insights into the role of this modification. Our preliminary results indicate that acylation occurs not only on newly-synthesized but also on the pre-existing PO, suggesting that acylation could also relate to myelin maintenance. 2. To determine the acylation site on the PO molecule. PO will be labeled with [3H]palmitic acid, digested with several proteases and the acyl- peptides isolated and sequenced. 3. To develop a cell-free system using deacylated PO and labeled acyl-CoA as substrates. We will carry out a detailed characterization of the acylating enzyme, localize the subcellular site of acylation unequivocally, isolate the acyltransferase and determine its substrate specificity, and determine the developmental and evolutionary changes of this enzyme. The studies proposed in this application will provide basic knowledge on the biology of PO acylation. Moreover, they will contribute to gain insights into normal myelination processes and ultimately to understand the pathophysiology of human peripheral nerve disorders.

Project Start
Project End
Budget Start
Budget End
Support Year
19
Fiscal Year
1993
Total Cost
Indirect Cost
Name
University of New Mexico
Department
Type
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Bharadwaj, D; Mold, C; Markham, E et al. (2001) Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 166:6735-41
Romero, I R; Morris, C; Rodriguez, M et al. (1998) Inflammatory potential of C-reactive protein complexes compared to immune complexes. Clin Immunol Immunopathol 87:155-62
Tetzloff, S U; Bizzozero, O A (1998) Palmitoylation of proteolipid protein from rat brain myelin using endogenously generated 18O-fatty acids. J Biol Chem 273:279-85
Sanchez, P; Tetzloff, S U; Bizzozero, O A (1998) Veratridine-induced depolarization reduces the palmitoylation of brain and myelin glycerolipids. J Neurochem 70:1448-57
Bryant, J E; Hutchings, K G; Moyzis, R K et al. (1997) Measurement of telomeric DNA content in human tissues. Biotechniques 23:476-8, 480, 482, passim
Melendez, R F; Bizzozero, O A (1996) Palmitoylation of myelin P0 protein is independent of its synthesis and parallels that of phospholipids. J Peripher Nerv Syst 1:34-41
Mold, C; Gurule, C; Otero, D et al. (1996) Complement-dependent binding of C-reactive protein complexes to human erythrocyte CR1. Clin Immunol Immunopathol 81:153-60
Chapin, J E; Davis, L E; Kornfeld, M et al. (1995) Neurologic manifestations of intravascular lymphomatosis. Acta Neurol Scand 91:494-9
Smith, J P; Hicks, P S; Ortiz, L R et al. (1995) Quantitative measurement of muscle strength in the mouse. J Neurosci Methods 62:15-9
Varela, M F; Sansom, C E; Griffith, J K (1995) Mutational analysis and molecular modelling of an amino acid sequence motif conserved in antiporters but not symporters in a transporter superfamily. Mol Membr Biol 12:313-9

Showing the most recent 10 out of 18 publications